An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer

1. Morgensztern, D.
2. Karaseva, N.
3. Felip, E.
4. Delgado, I.
5. Burdaeva, O.
6. Dómine, M.
7. Lara, P.
8. Paik, P.K.
9. Lassen, U.
10. Orlov, S.
11. Trigo, J.
12. Shomova, M.
13. Baker-Neblett, K.
14. Vasquez, J.
15. Wang, X.
16. Yan, L.
17. Mitrica, I.
18. DeYoung, M.P.
19. Garrido, P.